References
- Holland LJ, Kirwan JF, and Mercieca KJ. Effect of COVID-19 pandemic on glaucoma surgical practices in the UK. Br J Ophthalmol. 2021;1–5. doi:10.1136/bjophthalmol-2021-319062
- Toro MD, Brézin AP, Burdon M, et al. Early impact of COVID-19 outbreak on eye care: insights from EUROCOVCAT group. Eur J Ophthalmol. 2021;31(1):5–9.
- Racette L, Abu SL, Poleon S, et al. The impact of the Coronavirus disease 2019 pandemic on adherence to ocular hypotensive medication in patients with primary open-angle glaucoma. Ophthalmol. 2022;129(3):258–266.
- Ayub G, Vasconcelos JPC, Costa VP. The impact of Covid-19 in the follow-up of glaucoma patients in a tertiary center: a comparison between pre-pandemic and pandemic periods. Clin Ophthalmol. 2021;15:4381–4387.
- Awwad MA, Masoud M. Influence of COVID-19 on the prognosis and medication compliance of glaucoma patients in the Nile Delta Region. Clin Ophthalmol. 2021;15:4565–4572.
- O’Donnell O. Access to health care in developing countries: breaking down demand side barriers. Cad Saude Publica. 2007;23(12):2820–2834.
- Marson FAL. COVID-19 - 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced. Diagn Microbiol Infect Dis. 2020;98(2):115113.
- Feitosa MR, Parra RS, de Camargo HP, et al. COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil. Ann Gastroenterol. 2021;34(1):39–45.
- Rabiolo A, Morales E, Mohamed L, et al. Comparison of methods to detect and measure glaucomatous visual field progression. Trans Vision Sci Technol. 2019;8(5):2.
- Gardiner SK, Swanson WH, Goren D, et al. Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage. Ophthalmol. 2014;121(7):1359–1369.
- Poleon S, Racette L, Fifolt M, et al. Patient and provider perspectives on glaucoma treatment adherence: a delphi study in Urban Alabama. Optom Vis Sci. 2021;98(9):1085–1093.